The union at Samsung Biologics has initiated a strike demanding that management obtain prior union consent for new hiring and personnel evaluations [1].
The labor action represents a significant escalation in the struggle for worker influence over corporate governance. By seeking a vote on mergers, acquisitions, and staffing, the union is attempting to shift the balance of power from executive management to the workforce.
Union members are specifically requesting that the company secure pre-approval for all new recruitment and the processes used for employee performance reviews [1]. Additionally, the union is demanding a say in mergers and acquisitions, arguing that such corporate shifts directly impact employment stability and the direction of the company [1].
This movement is not isolated to a single entity. Other Samsung affiliates are also discussing potential strikes as labor tensions rise across the conglomerate [2]. The demands at Samsung Biologics highlight a broader trend of workers seeking to protect their rights against management-driven decisions.
Economic experts suggest the volatility is linked to the critical role of the technology sector in the national economy. Seo Eun-sook, a professor at Sangmyung University, said that semiconductors currently drive the overall South Korean economy [2]. She said that semiconductors account for one out of every four dollars in export earnings, or 25% [1].
Because of this outsized contribution, there are growing concerns that restrictions on worker rights or sudden management shifts could have wider economic implications [2]. The union believes that without a formal role in these decisions, workers remain vulnerable to corporate strategies that may prioritize short-term gains over long-term job security [1].
Management has not yet reached an agreement with the union on these points, and the strike continues as both sides weigh the impact on production and corporate stability [2].
“The union at Samsung Biologics is demanding that the company obtain prior union consent for new hiring, personnel evaluations, and mergers/acquisitions.”
This dispute signals a shift in South Korean labor relations, moving beyond simple wage negotiations toward a demand for 'co-determination' in corporate governance. If the union successfully secures a veto or consent right over M&A and hiring, it would set a precedent that limits the autonomy of executive management in one of the world's largest biotechnology firms and potentially trigger similar demands across other Samsung subsidiaries.
